Literature DB >> 27093064

Oxygen weaning after hospital discharge in children with bronchopulmonary dysplasia.

Jennifer Yeh1, Sharon A McGrath-Morrow1, Joseph M Collaco2.   

Abstract

BACKGROUND: In the United States, approximately 12,000 preterm infants are diagnosed with bronchopulmonary dysplasia (BPD) and many of these infants require supplemental oxygen after initial hospital discharge. In children with BPD we sought to identify factors associated with supplemental oxygen use after initial hospital discharge, factors associated with duration of supplemental oxygen use, and methods used to wean off supplemental oxygen in the home environment.
METHODS: All subjects (n = 420) with the diagnosis of BPD were recruited from a single center Bronchopulmonary Dysplasia Clinic between 2008 and 2013. Subject information was obtained from patient history records, patient demographics, and caregiver questionnaires.
RESULTS: Younger gestational age and having a Nissen fundoplication were associated with home supplemental oxygen use in subjects with BPD. Of the 154 subjects who received supplemental oxygen at home, 38% received flows ≤1/8 LPM, 30% received flows >1/8 LPM and ≤1/4 LPM, 21% received flows >1/4 LPM and ≤1/2 LPM, and 11% received flows >1/2 LPM. Among subjects receiving ≤1/8 LPM of oxygen, the median age of weaning off oxygen was 10.1 months, but increased depending on level of oxygen flow at initial outpatient visit. Of the 137 subjects weaned off of oxygen during the study period, weaning was not supervised by a physician in 32.1% of subjects.
CONCLUSION: Home supplemental oxygen use is common in infants diagnosed with BPD. In this study, the median age of weaning off supplemental oxygen was 10.1 months after initial hospital discharge. Unsupervised weaning of supplemental oxygen occurred in 32.1% of subjects with BPD. Pediatr Pulmonol. 2016;51:1206-1211.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  Bronchopulmonary dysplasia; oxygen; prematurity; respiratory outcomes

Mesh:

Substances:

Year:  2016        PMID: 27093064      PMCID: PMC5556369          DOI: 10.1002/ppul.23442

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  16 in total

Review 1.  Frontiers in pulmonary hypertension in infants and children with bronchopulmonary dysplasia.

Authors:  Joseph M Collaco; Lewis H Romer; Bridget D Stuart; John D Coulson; Allen D Everett; Edward E Lawson; Joel I Brenner; Anna T Brown; Melanie K Nies; Priya Sekar; Lawrence M Nogee; Sharon A McGrath-Morrow
Journal:  Pediatr Pulmonol       Date:  2012-07-06

2.  Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.

Authors:  Richard A Ehrenkranz; Michele C Walsh; Betty R Vohr; Alan H Jobe; Linda L Wright; Avroy A Fanaroff; Lisa A Wrage; Kenneth Poole
Journal:  Pediatrics       Date:  2005-12       Impact factor: 7.124

3.  Health-care utilization and respiratory morbidities in preterm infants with pulmonary hypertension.

Authors:  B D Stuart; P Sekar; J D Coulson; S E J Choi; S A McGrath-Morrow; J M Collaco
Journal:  J Perinatol       Date:  2013-01-17       Impact factor: 2.521

4.  Assessment of current strategies for weaning premature infants from supplemental oxygen in the outpatient setting.

Authors:  Kara Palm; Tregony Simoneau; Gregory Sawicki; Lawrence Rhein
Journal:  Adv Neonatal Care       Date:  2011-10       Impact factor: 1.968

5.  Intercenter differences in bronchopulmonary dysplasia or death among very low birth weight infants.

Authors:  Namasivayam Ambalavanan; Michele Walsh; Georgiy Bobashev; Abhik Das; Burton Levine; Waldemar A Carlo; Rosemary D Higgins
Journal:  Pediatrics       Date:  2010-12-13       Impact factor: 7.124

6.  Births: final data for 2013.

Authors:  Joyce A Martin; Brady E Hamilton; Michelle Jk Osterman; Sally C Curtin; T J Matthews
Journal:  Natl Vital Stat Rep       Date:  2015-01-15

7.  Home oxygen management of neonatal chronic lung disease in Western Australia.

Authors:  D T Silva; R Hagan; P D Sly
Journal:  J Paediatr Child Health       Date:  1995-06       Impact factor: 1.954

8.  Home oxygen therapy after preterm birth in Western Australia.

Authors:  A Saletti; S Stick; D Doherty; K Simmer
Journal:  J Paediatr Child Health       Date:  2004 Sep-Oct       Impact factor: 1.954

9.  [Home oxygen therapy in children with chronic respiratory failure].

Authors:  P Bertrand; C Alvarez; J Fabres; M Simonetti; I Sánchez
Journal:  Rev Med Chil       Date:  1998-03       Impact factor: 0.553

10.  Childhood obstructive sleep apnea associates with neuropsychological deficits and neuronal brain injury.

Authors:  Ann C Halbower; Mahaveer Degaonkar; Peter B Barker; Christopher J Earley; Carole L Marcus; Philip L Smith; M Cristine Prahme; E Mark Mahone
Journal:  PLoS Med       Date:  2006-08       Impact factor: 11.069

View more
  13 in total

1.  Predictors of length of stay for initial hospitalization in infants with bronchopulmonary dysplasia.

Authors:  Christopher B Morrow; Sharon A McGrath-Morrow; Joseph M Collaco
Journal:  J Perinatol       Date:  2018-06-08       Impact factor: 2.521

Review 2.  ATS Core Curriculum 2017: Part II. Pediatric Pulmonary Medicine.

Authors:  Paul E Moore; Jason T Poston; Debra Boyer; Emily Barsky; Jonathan Gaffin; Kathleen B Boyne; Kristie R Ross; Laura Beth Mann Dosier; Timothy J Vece; Alicia M Casey; Sebastian K Welsh; J Wells Logan; Edward G Shepherd; Pelton A Phinzy; Howard B Panitch; Christina M Papantonakis; Eric D Austin; Amir B Orandi; Maleewan Kitcharoensakkul; Mark K Abe; Amjad Horani; Jordan S Rettig; Jessica Pittman
Journal:  Ann Am Thorac Soc       Date:  2017-08

Review 3.  Bronchopulmonary Dysplasia: Then, Now, and Next.

Authors:  Michael C Tracy; David N Cornfield
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2020-09       Impact factor: 0.885

4.  Area deprivation and respiratory morbidities in children with bronchopulmonary dysplasia.

Authors:  Emma Banwell; Joseph M Collaco; Gabriela R Oates; Jessica L Rice; Lucia D Juarez; Lisa R Young; Sharon A McGrath-Morrow
Journal:  Pediatr Pulmonol       Date:  2022-05-21

5.  Impact of a protocol-driven unified service for neonates with bronchopulmonary dysplasia.

Authors:  Natalie Batey; Dushyant Batra; Jon Dorling; Jayesh Mahendra Bhatt
Journal:  ERJ Open Res       Date:  2019-03-25

6.  Aerodigestive sampling reveals altered microbial exchange between lung, oropharyngeal, and gastric microbiomes in children with impaired swallow function.

Authors:  Claire Duvallet; Kara Larson; Scott Snapper; Sonia Iosim; Ann Lee; Katherine Freer; Kara May; Eric Alm; Rachel Rosen
Journal:  PLoS One       Date:  2019-05-20       Impact factor: 3.240

Review 7.  Bronchopulmonary dysplasia: what are its links to COPD?

Authors:  Sharon A McGrath-Morrow; Joseph M Collaco
Journal:  Ther Adv Respir Dis       Date:  2019 Jan-Dec       Impact factor: 4.031

Review 8.  Influences of environmental exposures on preterm lung disease.

Authors:  Joseph M Collaco; Brianna C Aoyama; Jessica L Rice; Sharon A McGrath-Morrow
Journal:  Expert Rev Respir Med       Date:  2021-06-17       Impact factor: 3.772

9.  Risk prediction tool for use and predictors of duration of postoperative oxygen therapy in children undergoing non-cardiac surgery: a case-control study.

Authors:  Maliwan Oofuvong; Siriwimol Ratprasert; Thavat Chanchayanon
Journal:  BMC Anesthesiol       Date:  2018-11-02       Impact factor: 2.217

10.  Home Oxygen Therapy for Children. An Official American Thoracic Society Clinical Practice Guideline.

Authors:  Don Hayes; Kevin C Wilson; Katelyn Krivchenia; Stephen M M Hawkins; Ian M Balfour-Lynn; David Gozal; Howard B Panitch; Mark L Splaingard; Lawrence M Rhein; Geoffrey Kurland; Steven H Abman; Timothy M Hoffman; Christopher L Carroll; Mary E Cataletto; Dmitry Tumin; Eyal Oren; Richard J Martin; Joyce Baker; Gregory R Porta; Deborah Kaley; Ann Gettys; Robin R Deterding
Journal:  Am J Respir Crit Care Med       Date:  2019-02-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.